Free Trial

Novavax (NVAX) SEC Filings & 10K Form

$15.03
-0.22 (-1.44%)
(As of 05/31/2024 ET)

Recent Novavax SEC Filings

DateFilerForm TypeView
05/20/2024
1:42 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/20/2024
5:09 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
05/15/2024
8:15 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
1:39 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
7:05 AM
Novavax (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
7:07 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
3:53 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/07/2024
4:21 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/07/2024
1:43 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
05/06/2024
3:43 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/06/2024
5:00 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form PREC14A
04/29/2024
6:58 AM
Novavax (Filer)
Form DEFA14A
04/29/2024
7:01 AM
Novavax (Filer)
Form ARS
04/29/2024
6:54 AM
Novavax (Filer)
Form DEF 14A
04/15/2024
11:18 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
04/15/2024
5:00 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D
03/26/2024
6:00 PM
Casey Mark J (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:00 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:01 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:02 PM
Novavax (Issuer)
O'Hara Elaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:03 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
5:11 PM
Jacobs John C (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:45 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:46 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:46 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:39 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:40 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:40 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:30 PM
Novavax (Issuer)
O'Hara Elaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
7:07 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:30 AM
Novavax (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
5:02 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
12:59 PM
MORGAN STANLEY (Filed by)
Novavax (Subject)
Form SC 13G
01/31/2024
7:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
4:00 PM
Jacobs John C (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
7:57 AM
Novavax (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/08/2024
8:25 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
4:12 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
7:45 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2023
3:36 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
7:05 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
🚀 Tap into this explosive trade opportunity asap (Ad)

I learned about these explosive stocks during my two decades on Wall Street… And used them to help grow my old hedge fund from just a few million to over $700 million dollars*. So it’s safe to say… these bad boys work. What’s the secret behind these special trades? Well, right now, I’m going public with the unique strategy behind these “Calendar Stocks”…

Go here to see how you can exploit my next “Calendar Stock”.
11/09/2023
6:32 AM
Novavax (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2023
4:30 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
3:43 PM
Novavax (Issuer)
Rodgers Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
4:16 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
3:47 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
3:37 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
5:08 AM
Novavax (Subject)
SK Bioscience Co., Ltd. (Filed by)
Form SC 13G
08/08/2023
6:56 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
7:05 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
6:48 AM
Novavax (Filer)
Form 424B5
08/08/2023
6:20 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
5:30 AM
Novavax (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/11/2023
4:12 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2023
3:30 PM
Novavax (Filer)
Form DEFA14A
06/29/2023
3:32 PM
Novavax (Filer)
Form DEFA14A
06/27/2023
3:31 PM
Herrmann John A III (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
3:32 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:39 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/21/2023
3:40 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:43 PM
Alton Gregg H (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:44 PM
DOUGLAS RICHARD (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:46 PM
King Rachel K. (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:47 PM
MCGLYNN MARGARET G (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:47 PM
MOTT DAVID M (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:48 PM
Novavax (Issuer)
Rodgers Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:49 PM
Novavax (Issuer)
YOUNG JAMES F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:NVAX) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners